ELIZABETH POTTER: Open Payments
NPI 1942691720 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 38 payments from 14 companies in 2025. Trend: 2023 $22 · 2024 $57 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $246 |
| Alkermes, Inc. | 5 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Lundbeck LLC | 3 | $79 |
| Almatica Pharma LLC | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
Products named: CAPLYTA, SPRAVATO, TRINTELLIX, LYBALVI, REXULTI, LOREEV XR, Auvelity, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
